Stephen Ostroff

Acting commissioner

Stephen Ostroff, M.D., is the Food and Drug Administration’s acting commissioner of food and drugs. Before being named acting commissioner, Ostroff served as the FDA’s chief scientist since January 2014. In this capacity, he was responsible for leading and coordinating FDA's cross-cutting scientific and public health efforts. Ostroff graduated from the University of Pennsylvania School of Medicine.

 

Wed, 01/13/2016 - 16:06
FDA 2015: A Look Back (and Ahead), Part 3Our progress addressing food safety, tobacco use, and antimicrobial resistance
Mon, 01/18/2016 - 14:45
In this third and final article reflecting on the FDA’s work to protect and promote public health during 2015, we’ll take a look at our achievements in food, antimicrobial resistance, and tobacco product regulation. In part one I shared the FDA’s…
FDA 2015: A Look Back (and Ahead), Part 2A review of FDA’s effect on medical product safety and oversight
Thu, 01/14/2016 - 12:19
In my first look back on the FDA’s 2015 accomplishments, I focused on our achievements in medical product innovation and our constant drive to make available safe, effective, and innovative products. Because the FDA’s responsibility covers the…
FDA 2015: A Look Back (and Ahead), Part 1A summary of medical product innovation
Wed, 01/13/2016 - 16:06
Since March 2015 it’s been my pleasure to serve as the Food and Drug Administration’s (FDA) Acting Commissioner. The FDA has broad responsibilities, and I’d like to share some important accomplishments during 2015. Tasked with overseeing products…